Oxford Drug Design
PrivateLast Round
Crowdfunding
Mar 4, 2026
Est. Valuation
$15.17M
Total Funding Raised
$8.29M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oxford Drug Design operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Crowdfunding round in March 2026.
Oxford Drug Design is a biotechnology company that discovers and develops novel therapeutics for cancer and other diseases using a proprietary AI and machine learning platform with a core expertise in aminoacyl-tRNA synthetase (aaRS) enzymes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Drug Design Comparables
Compare Oxford Drug Design with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iktos | 79% | |
| Charm Therapeutics | 78% | |
| Optibrium | 76% |
For institutional investors. Book with your work email.
Oxford Drug Design Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Mar 4, 2026 | ||||
| Grant | Feb 20, 2025 | ||||
| Grant | Sep 26, 2024 | ||||
| Grant | May 22, 2024 | ||||
| Debt | May 19, 2022 | ||||
VC Round | Nov 5, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oxford Drug Design Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | Debt, VC Round |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| IP Group | VC Round |
| o2h ventures | Debt, VC Round |
| Department of Health and Social Care | VC Round, Grant |
| Meltwind Advisory | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 423% MoM, from 298 to 1.6K.
- Apr 16, 2026
Monthly visitors increased 5825% MoM, from 24 to 1.4K.
For institutional investors. Book with your work email.
Oxford Drug Design Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oxford Drug Design's valuation, stock price, and market status.
Is Oxford Drug Design a public or private company?
Oxford Drug Design is a private company.
What is the current stock price of Oxford Drug Design?
Oxford Drug Design is a private company, so its shares have no public market price. Caplight tracks Oxford Drug Design's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oxford Drug Design worth (valuation)?
Oxford Drug Design's valuation is estimated at $15.2M based on funding round data.
Can I buy Oxford Drug Design stock?
Oxford Drug Design shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oxford Drug Design's last funding round?
Oxford Drug Design's most recent funding round was Crowdfunding on March 4, 2026.
Who are the main investors in Oxford Drug Design?
Key investors in Oxford Drug Design include o2h ventures.
Will Oxford Drug Design IPO soon?
No public IPO plans have been announced for Oxford Drug Design.
How can I track Oxford Drug Design secondary market activity?
Caplight tracks bids, offers, and trades in Oxford Drug Design's shares on secondary markets.